Table 3.
Overall and Subgroup Trends for Drugs Used in Nebulization Therapy
| Drugs | Overall (in %) | SEC A (in %) | SEC B (in %) | Male (in %) | Female (in %) |
|---|---|---|---|---|---|
| Formoterol + Budesonide | 46 | 52 | 39 | 45 | 46 |
| Budesonide | 31 | 33 | 24 | 26 | 34 |
| Levosalbutamol + Ipratropium | 29 | 33 | 24 | 34 | 26 |
| Levosalbutamol | 20 | 20 | 18 | 19 | 22 |
| Salbutamol | 19 | 19 | 18 | 19 | 18 |
| Levosalbutamol + Budesonide | 3 | 2 | 4 | 4 | 2 |
| Glycopyrrolate | 3 | 6 | 0 | 6 | 0 |
| Salmeterol + Fluticasone Propionate | 2 | 2 | 2 | 4 | 0 |